|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products. |
| 公司地址
| 6027 Edgewood Bend Court, San Diego, CA, USA, 92130 |
| 電話號碼
| +1 858 617-7600 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.neurocrine.com |
| 員工數量
| 2000 |
| Mr. Andrew Ratz |
Chief Technical Operations Officer |
-- |
15/04/2026 |
| Mr. Eric S. Benevich |
Chief Commercial Officer |
美元 668.69K |
15/04/2026 |
| Mr. Darin M. Lippoldt |
Chief Legal Officer and Corporate Secretary |
-- |
15/04/2026 |
| Dr. Kyle W. Gano, PhD |
Director, President and Chief Executive Officer |
美元 920.00K |
15/04/2026 |
| Mr. Matthew C. Abernethy |
Chief Financial Officer and Principal Accounting Officer |
美元 725.91K |
15/04/2026 |
| Ms. Julie S. Cooke |
Chief Human Resources Officer |
-- |
15/04/2026 |
| Dr. Jude Onyia, PhD |
Chief Scientific Officer |
美元 720.52K |
15/04/2026 |
| Mr. David W. Boyer |
Chief Corporate Affairs Officer |
-- |
15/04/2026 |
| Dr. Ingrid Delaet, PhD |
Chief Regulatory Officer |
-- |
15/04/2026 |
| Dr. Sanjay Keswani, M.B.B.S. |
Chief Medical Officer |
美元 379.17K |
15/04/2026 |
|
|
| Mr. Gary A. Lyons |
Independent Director |
15/04/2026 |
| Dr. Kevin C. Gorman,PhD |
Director |
15/04/2026 |
| Mr. Richard F. Pops |
Independent Director |
15/04/2026 |
| Ms. Shalini Sharp |
Independent Director |
15/04/2026 |
| Dr. William H. Rastetter,PhD |
Chairman of the Board |
15/04/2026 |
| Mr. George J. Morrow |
Independent Director |
15/04/2026 |
| Dr. Stephen A. Sherwin, M.D. |
Independent Director |
15/04/2026 |
| Ms. Leslie V. Norwalk, Esq. |
Independent Director |
15/04/2026 |
| Dr. Kyle W. Gano, PhD |
Director, President and Chief Executive Officer |
15/04/2026 |
| Ms. Johanna Mercier |
Independent Director |
15/04/2026 |
| Ms. Christine A. Poon |
Independent Director |
15/04/2026 |
|
|
|
|
